SCHEMBL23430833

SCHEMBL23430833

CNC1OC(CO)[C@H](OC2OC(CO)C(O)C(O)C2O)C(O)[C@@H]1O

nearest known ligand 0.57

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ LGALS8 O00214 2/20 0.53
▸ LGALS3 P17931 2/20 0.53
▸ LGALS4 P56470 2/20 0.53
▸ CA12 O43570 8/20 0.50
▸ CA1 P00915 8/20 0.50
▸ CA2 P00918 8/20 0.50
▸ CA9 Q16790 8/20 0.50
▸ CA14 Q9ULX7 8/20 0.50
▸ MEN1 O00255 1/20 0.48
▸ KMT2A Q03164 1/20 0.48
▸ AMY1A P0DUB6 1/20 0.47
▸ PYGB P11216 1/20 0.47
▸ AMY2A P04746 1/20 0.46
▸ FGF1 P05230 1/20 0.45
▸ FGF2 P09038 1/20 0.45
▸ VEGFA P15692 1/20 0.45
▸ HPSE Q9Y251 1/20 0.45
▸ TYR P14679 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16217741 1.00 LGALS8 (0.53) LGALS8LGALS3LGALS4CA12CA1
SCHEMBL21894588 1.00 LGALS8 (0.53) LGALS8LGALS3LGALS4CA12CA1
SCHEMBL23617758 1.00 LGALS8 (0.53) LGALS8LGALS3LGALS4CA12CA1
SCHEMBL22296782 1.00 LGALS8 (0.53) LGALS8LGALS3LGALS4CA12CA1
SCHEMBL23735640 1.00 LGALS8 (0.53) LGALS8LGALS3LGALS4CA12CA1
SCHEMBL21698210 1.00 LGALS8 (0.53) LGALS8LGALS3LGALS4CA12CA1
SCHEMBL18976778 0.90 MEN1 (0.49) LGALS8LGALS3LGALS4MEN1KMT2A
SCHEMBL22296747 0.87 MEN1 (0.45) LGALS8LGALS3LGALS4CA12CA1
SCHEMBL16221568 0.86 LGALS8 (0.51) LGALS8LGALS3LGALS4CA12CA1
SCHEMBL22372512 0.85 LGALS8 (0.56) LGALS8LGALS3LGALS4CA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3828275-A1 COMPOSITIONS AND METHODS FOR MODULATING TTR EXPRESSION Ionis Pharmaceuticals, Inc. (US) 2021-06-02 — — EP disclosed
Send feedback